Search
Acylcarnitine (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine
smpdb.ca/view/SMP0123901Metabolic(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl-CoA reacts with L-carnitine to form (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreEnzymes: Solute carrier family 22 member 5Acylcarnitine (9S,10E,12S,13S)-9,12,13-trihydroxyoctadec-10-enoylcarnitine
smpdb.ca/view/SMP0124324Metabolic(9S,10E,12S,13S)-9,12,13-trihydroxyoctadec-10-enoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (9S,10E,12S,13S)-9,12,13-trihydroxyoctadec-10-enoyl-CoA reacts with L-carnitine to form (9S,10E,12S,13S)-9,12,13-trihydroxyoctadec-10-enoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreEnzymes: Solute carrier family 22 member 5Menatetrenone
go.drugbank.com/drugs/DB12148InvestigationalMenatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma.
Categories: Vitamin KProducts: GLAKAY ( 15 MG ), GLAKAY (15 MG.)Fimasartan
go.drugbank.com/drugs/DB09279InvestigationalIt has been found to be safe when administered with hydrochlorothiazide (a diuretic) in clinical trials.
Categories: Heterocyclic Compounds, 1-RingSynonyms: BR1015-1, BR1015-3Pyritinol
go.drugbank.com/drugs/DB13084InvestigationalPyritinol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.
Categories: Heterocyclic Compounds, 1-RingProducts: ENCEFABOL 100 MG, ENCEFABOL® 200 MG SUSPENSIONDermatophagoides pteronyssinus
go.drugbank.com/drugs/DB10401ApprovedInvestigationalThis combination is approved for as a year-round, once-a-day tablet that's dissolved under the tongue as a treatment for dust mite allergies.
Mixtures: SLITone ULTRA D. pteronyssinus/ D. farinae, Acarizax 12 SQ-HDM Oral Lyophilisate TabletProducts: Standardized Mite, Dermatophagoides pteronyssinus, Intradermal, 30 AU per mL, Standardized Mite D PteronyssinusVelaglucerase alfa
go.drugbank.com/drugs/DB06720ApprovedVelaglucerase alfa is a gene-activated human recombinant glucocerebrosidase used for the treatment of Type 1 Gaucher disease, caused by a deficiency of the lysosomal enzyme glucocerebrosidase. … Additionally, Velaglucerase alfa has also been investigated for use in Type 3 Gaucher disease.
Products: VPRIV 400 ÜNİTE İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 1 ADET, VPRIV 400 ÜNİTE İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 5 ADETAmithiozone
go.drugbank.com/drugs/DB12829InvestigationalAmithiozone has been used in trials studying the treatment of Mycobacterium Avium-intracellulare Infection.
Products: CITAZON 150 MG TABLET, 50 ADET, CİTAZON 150 MG TABLET, 500 ADETImidafenacin
go.drugbank.com/drugs/DB09262InvestigationalIt is marketed in Japan under the tradenames Staybla by Ono Pharmaceutical and Uritos by Kyojin Pharmaceutical. … It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder.
Categories: Heterocyclic Compounds, 1-Ring, Cytochrome P-450 SubstratesProducts: URITOS (TABLETS 0.1 MG), URITOS TABLETS 0.1 MGAclidinium
go.drugbank.com/drugs/DB08897ApprovedIt has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.
Mixtures: Duaklir Genuair 340/12 mcg Inhalation Powder, DUAKLIR®GENUAIR®340/12MCG/DOSIS.Products: EKLIRA®GENUAIR® 322 MCG/DOSIS, Eklira Genuair 322 mcg Inhalation Powder